Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells

Blood Advances(2023)

引用 2|浏览1
暂无评分
摘要
•The pathogenic gene expression programs in LSCs are driven by the aberrant activity of enhancer elements.•Histone acetyltransferase inhibition effectively disrupts the AML enhancer regulatory axis.
更多
查看译文
关键词
stem cells,oncogene-dependent
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要